E2F3 and colorectal carcinoma: CircPRTM5 exerts critical regulatory role in CRC by sponging miR‐377 to induce E2F3 expression and promoting cell cycle‐associated proteins cyclinD1 and CDK2 expression, which opens up new insight into the potential treatment of CRC in humans.